IDiyas

For the Inventor, By the Inventor

Donaustauf, Germany

Peter H Ermann

USPTO Granted Patents = 13


Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 105(Granted Patents)


Company Filing History:

goldMedal13 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1986-1998

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5705645 - Hereroaryl derivatives of monocyclic beta-lactam antibiotics (1998-01-06),
2. 5420277 - Intermediates for the preparation of heteroaryl derivatives of (1995-05-30),
3. 5318963 - Heterocyclic hydrazide derivatives of monocyclic .beta.-lactam (1994-06-07),
4. 5290929 - Heteroaryl derivatives of monocyclic beta-lactam antibiotics (1994-03-01),
5. 5270334 - 4-methoxy-5-methyl-pyran-3-ol natural products and derivatives thereof (1993-12-14),
6. 5266593 - Substituted pyran derivatives having antiinfective activity (1993-11-30),
7. 5037983 - 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics (1991-08-06),
8. 4904775 - Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics (1990-02-27),
9. 4871841 - 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines (1989-10-03),
10. 4801705 - 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines (1989-01-31),
11. 4777252 - 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines (1988-10-11),
12. 4633017 - N-hydroxy protecting groups and process for the preparation of (1986-12-30),
13. 4581170 - N-hydroxyl protecting groups and process and intermediates for the (1986-04-08),

Title: The Innovations of Peter H. Ermann: A Pioneer in Antibacterial Compounds

Introduction

Peter H. Ermann, an innovative inventor based in Donaustauf, Germany, has made significant contributions to the field of antibacterial pharmaceuticals. With a portfolio of 13 patents, he has dedicated his research to developing novel compounds that exhibit antibacterial activity, which is crucial in combating resistant strains of bacteria.

Latest Patents

One of Ermann's latest patents focuses on heteroaryl derivatives of monocyclic beta-lactam antibiotics. The compounds described in his patent demonstrate novel antibacterial properties through a specific formula. These compounds have received attention for their potential efficacy in medical applications, reflecting Ermann's commitment to addressing critical health challenges.

In addition, his work includes various intermediates necessary for preparing these innovative compounds, highlighting his thorough approach to the development process.

Career Highlights

Ermann's professional journey includes a prominent role at E.R. Squibb & Sons, Inc., where he has worked diligently to advance research in pharmaceutical formulations. Throughout his career, he has focused on creating effective solutions for bacterial infections, enhancing treatment options for patients worldwide.

Collaborations

Collaborating with accomplished scientists such as Henner Straub and Joseph E. Sundeen, Ermann has combined expertise to push the boundaries of antibacterial research. These partnerships have allowed for a fruitful exchange of ideas, leading to the birth of innovative solutions in the field.

Conclusion

Peter H. Ermann is a distinguished inventor whose contributions to antibacterial research have far-reaching impacts. As he continues to pursue new innovations in his field, his work will be pivotal in advancing medical treatments and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…